Newsletter
Sign up for the Fund's newsletter and get the lastest news, calls and events
| Titel Sort descending | Periode | Program | |
|---|---|---|---|
| Activation of Kv3 channels as a novel and innovative approach to treat schizophrenia | 2016 - 2019 | Industrial Researcher
|
|
|
Activation of Kv3 channels as a novel and innovative approach to treat schizophrenia
Period
2016 - 2019
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
40.57 Invested
1.1 mill. Budget
2.7 mill. Partners
University of Copenhagen, H LUNDBECK A/S People
H LUNDBECK A/S
Read more about the project
| |||
| ADCendo ApS - A biotech spinout developing novel anti-cancer drugs in the form of antibody drug conjugates (ADCs) | 2019 - 2020 | Innobooster
|
|
|
ADCendo ApS - A biotech spinout developing novel anti-cancer drugs in the form of antibody drug conjugates (ADCs)
Period
2019 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
30 Invested
483.600 Budget
1.6 mill. Partners
ADCendo ApS People
ADCendo ApS
Read more about the project
| |||
| ADCendo ApS - first-in-class targeted cancer drugs | 2019 - 2020 | Innofounder
|
|
|
ADCendo ApS - first-in-class targeted cancer drugs
Period
2019 - 2020
Region
Region Hovedstaden Program
Innofounder Area
Biotek, Medico og Sundhed Investment
Percentage
100 Invested
460.000 Budget
460.000 Partners
ADCendo ApS People
ADCendo ApS
Read more about the project
| |||
| Adherence through cloud-based Personalised Treatment for Type 2 Diabetes ADAPT-T2D ADAPT-T2D | 2019 - 2024 | Grand Solutions
|
|
|
Adherence through cloud-based Personalised Treatment for Type 2 Diabetes ADAPT-T2D ADAPT-T2D
Period
2019 - 2024
Region
Region Hovedstaden Program
Grand Solutions Area
Biotek, Medico og Sundhed Investment
Percentage
52.12 Invested
17.1 mill. Budget
32.9 mill. Partners
Novo Nordisk A/S, Aalborg Universitetshospital, Region Sjælland, Aalborg University, Technical University of Denmark, University of Cambridge, Glooko AB People
NOVO NORDISK A/S
Read more about the project
| |||
| Adipose tissue function, insulin receptors and adipogenesis | 2017 - 2020 | Industrial Researcher
|
|
|
Adipose tissue function, insulin receptors and adipogenesis
Period
2017 - 2020
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
64.58 Invested
1.1 mill. Budget
1.7 mill. Partners
University of Southern Denmark, Novo Nordisk A/S People
Novo Nordisk A/S
Read more about the project
| |||
| Advanced characterization of large scale fermentations | 2019 - 2021 | Industrial Researcher
|
|
|
Advanced characterization of large scale fermentations
Period
2019 - 2021
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
46.94 Invested
828.000 Budget
1.8 mill. Partners
Technical University of Denmark, FreeSense ApS People
FreeSense ApS
Read more about the project
| |||
| Advanced modelling for prediction and control of related substances in an antibiotic fermentation processes | 2019 - 2022 | Industrial Researcher
|
|
|
Advanced modelling for prediction and control of related substances in an antibiotic fermentation processes
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
47.73 Invested
1.1 mill. Budget
2.2 mill. Partners
Technical University of Denmark, LEO PHARMA A/S People
LEO PHARMA A/S
Read more about the project
| |||
| Advanced wound care adhesives with new functional properties. | 2017 - 2020 | Industrial Researcher
|
|
|
Advanced wound care adhesives with new functional properties.
Period
2017 - 2020
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
50.23 Invested
1.1 mill. Budget
2.1 mill. Partners
Technical University of Denmark, Coloplast A/S People
Coloplast A/S
Read more about the project
| |||
| Advancing ACT technology to expand patient reach | 2020 - 2023 | Industrial Researcher
|
|
|
Advancing ACT technology to expand patient reach
Period
2020 - 2023
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
100 Invested
1.1 mill. Budget
1.1 mill. Partners
University of Copenhagen, CBio A/S People
CBio A/S
Read more about the project
| |||
| Advancing biological solutions for biofouling | 2019 - 2022 | Industrial Researcher
|
|
|
Advancing biological solutions for biofouling
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
56.02 Invested
1.1 mill. Budget
1.9 mill. Partners
Aarhus University, Novozymes A/S People
Novozymes A/S
Read more about the project
| |||
| Advancing KP405 - A Novel, First-in-Class, Disease Modifying Treatment for Parkinson's Disease | 2019 - 2020 | Innobooster
|
|
|
Advancing KP405 - A Novel, First-in-Class, Disease Modifying Treatment for Parkinson's Disease
Period
2019 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
33 Invested
4.0 mill. Budget
12.0 mill. Partners
Kariya Pharmaecuticals IVS People
Kariya Pharmaceuticals ApS
Read more about the project
| |||
| Affective Design for improved Health Outcomes for Rheumatology Patients using Digital Health Technology | 2019 - 2022 | Industrial Researcher
|
|
|
Affective Design for improved Health Outcomes for Rheumatology Patients using Digital Health Technology
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
51.29 Invested
1.1 mill. Budget
2.1 mill. Partners
IT University of Copenhagen, DAMAN P/S People
DAMAN P/S
Read more about the project
| |||
| Afprøvning af 3D printede bioimplantater til rekonstruktion af ansigtet | 2018 - 2020 | Innobooster
|
|
|
Afprøvning af 3D printede bioimplantater til rekonstruktion af ansigtet
Period
2018 - 2020
Region
Region Syddanmark Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
31.79 Invested
461.000 Budget
1.5 mill. Partners
Particle3D People
Ossiform ApS
Read more about the project
| |||
| AI augmented training of doctors - skin cancer diagnostics AISK AISK | 2020 - 2022 | Grand Solutions
|
|
|
AI augmented training of doctors - skin cancer diagnostics AISK AISK
Period
2020 - 2022
Region
Region Hovedstaden Program
Grand Solutions Area
Biotek, Medico og Sundhed Investment
Percentage
74.67 Invested
10.0 mill. Budget
13.3 mill. Partners
Herlev Hospital, MelaTech, Technical University of Denmark, Odense University Hospital, Gentofte Hospital, Bispebjerg Hospital, Copenhagen University Hospital (Rigshospitalet), Melanoma Institute Australia, Sydney People
MelaTech ApS
Read more about the project
| |||
| AI for acoustic assessment of fetal health | 2020 - 2023 | Industrial Researcher
|
|
|
AI for acoustic assessment of fetal health
Period
2020 - 2023
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
61.82 Invested
1.1 mill. Budget
1.7 mill. Partners
Aalborg University, VIEWCARE A/S People
VIEWCARE A/S
Read more about the project
| |||